Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: HIV Med. 2012 Jan 26;13(5):276–290. doi: 10.1111/j.1468-1293.2011.00973.x

Figure 3. Expression pattern of cytokeratin 5 in untreated and Zidovudine treated gingival raft cultures.

Figure 3

Primary gingival keratinocytes were grown in raft cultures and treated with different concentrations of Zidovudine at either day 0 or day 8.

(Panels A, G, M, and S) untreated rafts; (Panels B, H, N and T) rafts treated with 0.5 µg/ml Zidovudine; (Panels C, I, O, and U) rafts treated with 1 µg/ml Zidovudine; (Panels D, J, P, and V) rafts treated with 2 µg/ml, the cMax of Zidovudine; (Panels E, K, Q, and W) rafts treated with 4 µg/ml Zidovudine; (Panels F, L, R, and X) rafts treated with 6 µg/ml Zidovudine. Rafts were harvested at the indicated timepoints (DPT denotes days post treatment) and stained with anti-cytokeratin 5. Images are at 20 X original magnification.